Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DW68 | ISIN: US74168J1016 | Ticker-Symbol:
NASDAQ
31.03.25
21:41 Uhr
1,970 US-Dollar
+0,015
+0,77 %
1-Jahres-Chart
PRIME MEDICINE INC Chart 1 Jahr
5-Tage-Chart
PRIME MEDICINE INC 5-Tage-Chart

Aktuelle News zur PRIME MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.03.Wedbush Forecasts Prime Medicine FY2029 Earnings1
21.03.Why Prime Medicine Stock Was Climbing Higher This Week1
PRIME MEDICINE Aktie jetzt für 0€ handeln
19.03.Why Prime Medicine Stock Is Soaring Today1
19.03.H.C. Wainwright maintains Buy on Prime Medicine stock, $10 target3
19.03.JMP maintains $10 target on Prime Medicine stock1
18.03.Prime Medicine, Inc. - 8-K, Current Report-
18.03.Prime Medicine, Inc.: Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)99-- Prime Editing has potential to be best-in-class approach for AATD -- -- Previously undisclosed program now emerging from within liver platform; leverages proprietary, universal liver LNP -- --...
► Artikel lesen
04.03.Citizens JMP maintains $10 target on Prime Medicine stock1
03.03.Prime Medicine GAAP EPS of -$1.65 misses by $0.30, revenue of $2.98M misses by $3.4M3
28.02.Prime Medicine, Inc.: Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates1.339-- On track to report initial data from Phase 1/2 clinical trial of PM359 for p47phox CGD in 2025 -- -- IND-enabling studies ongoing for PM577 for Wilson's Disease; expect to file IND and/or CTA...
► Artikel lesen
28.02.Prime Medicine, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
28.02.Prime Medicine, Inc. - 10-K, Annual Report-
28.02.Prime Medicine, Inc. - 8-K, Current Report-
13.01.Prime Medicine, Inc. - 8-K, Current Report-
29.12.24Prime Medicine, Inc. (PRME): Is This Gene Therapy Stock a Good Buy Right Now?3
13.11.24Prime Medicine GAAP EPS of -$0.44 misses by $0.01, revenue of $0.21M misses by $5.7M3
12.11.24Prime Medicine, Inc. - 8-K, Current Report-
24.10.24Prime Medicine, Inc.: Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress10
24.10.24Prime Medicine, Inc. - 8-K, Current Report-
15.10.24Prime Medicine, Inc.: Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings6
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1